ADIL

Conviction 80HealthcareScan · Mon, Aug 10, 2026

ADIL$4.26+6.91%

ResistanceSupportVol 14Insider buy

Vol MA14 74.55K

May 11May 28Jun 16Jul 6Jul 23Aug 10

ADIAL PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.adial.com ↗

Price4.26

Change+6.91%

Gap+2.01%

Rel volume0.14×

Avg volume60.65K

Avg $ vol216.81K

SMA 203.23

SMA 502.86

SMA 2001.56

Price vs 50+48.94%

Price vs 200+172.45%

MA stackbullish

50/200 cross—

Supertrendup · 3.49

RSI (14)68

MACD hist0.13

MACD crossbull · 8d

Stoch %K / %D71 / 74

ADX (14)46

+DI / −DI37 / 11

RSI divergence—

MACD divergence—

ATR %+8.89%

ADR %9.08%

52w high4.80

52w low0.1370

From 52w high-11.35%

Above 52w low+3005.84%

New 52w highNo

SqueezeOff

Bollinger width77.13%

%B0.91

Donchian pos70.62%

Donchian high4.99

Donchian low2.50

AVWAP (52w high)3.35

vs AVWAP high+26.85%

AVWAP (52w low)2.84

vs AVWAP low+49.88%

OBV trendUp

Chaikin MF (20)0.38

Today vs 20d0.14×

Avg vol (14d)74.55K

Avg vol (20d)60.65K

Avg $ vol (20d)216.81K

Market cap9.12M

RS 3m (vs SPY)+174.58%

RS 6m (vs SPY)+2791.00%

RS line new highNo

Trend template8/8

Technical rank94.5

1 week+16.90%

1 month+53.06%

3 months+197.55%

6 months+36.38%

1 year+999.48%

YTD+1678.10%

P/E-1.14

P/B2.45

P/S—

P/FCF-1.39

EPS-11.93

Div yield—

ROE-214.60%

ROA-152.61%

Debt/Eq—

Current3.18

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth39.56%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.24M

Revenue—

Net income-2.02M

Gross profit—

Free cash flow-6.56M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.14M

Employees6

ListedFri, Jul 27, 2018

Free float1.41M

Float %98.6%

Short interest243.62K

Days to cover5.3d

Short volume51.0%

Squeeze score67 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank94.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.98

Support2.36

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ADIL

All disclosures →

No recent disclosed trades by Congress in ADIL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ADIL · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Coastlands Capital LP 10% owner · Common Stock · 2026-07-16	Buy	1.23K	$3K	2026-07-16	2026-07-16
Coastlands Capital LP 10% owner · Common Stock · 2026-07-14	Buy	2K	$5K	2026-07-14	2026-07-16
Coastlands Capital LP 10% owner · Common Stock · 2026-07-10	Buy	1.7K	$5K	2026-07-10	2026-07-13
Coastlands Capital LP 10% owner · Common Stock · 2026-07-09	Buy	10.05K	$28K	2026-07-09	2026-07-13
Davidson Matt Chief Development Officer · Stock Option (Right to Buy) · 2026-06-12	Grant	232.42K	—	2026-06-12	2026-06-16
Davidson Matt Chief Development Officer · Common Stock · 2026-06-12	Grant	232.42K	—	2026-06-12	2026-06-16
Young Wendy B. Director · Pre-funded Warrant · 2026-06-12	Buy	36.38K	$100K	2026-06-12	2026-06-16
Davidson Matt Chief Development Officer · Series A Preferred Stock · 2026-06-11	Grant	101.298	—	2026-06-11	2026-06-16
Davidson Matt Chief Development Officer · Common Stock · 2026-06-11	Grant	61.65K	—	2026-06-11	2026-06-16
Davidson Matt Chief Development Officer · Common Stock · 2026-06-11	Grant	3.43K	—	2026-06-11	2026-06-16

SEC filings

EDGAR filings in ADIL · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.